bluuebunny/crossref_metadata_2025_split huggingface dataset:
Orthotic Helmet Therapy for Deformational Plagiocephaly: Stratifying Outcomes by Insurance
Authors: Hauc Sacha C. , Junn Adam H. , Long Aaron S. , Rivera Jean Carlo , Littlefield Timothy R. , Ihnat Jacqueline M. , Shah Hemali P. , Pondugula Nishita , Almeida Mariana N. , Alper David P. , Persing John A. , Alperovich Michael 
Published: January 2023

Objective Deformational Plagiocephaly (DP) is commonly treated with cranial orthosis, or helmet therapy. A large, national study on the impact of insurance status on helmet outcomes is lacking. We assessed treatment outcomes for helmet therapy based on insurance status. Design This was a retrospective data analysis of patients referred to Cranial Technologies, Inc for helmet therapy between 2014–2020 across 21 states. Patients, Participants There were a total of 211,417 patients referred for helmeting, of whom 141,513 received helmet therapy. Main Outcomes Measures Multivariate regression was used to assess the relationship of insurance status with post-treatment residual flattening, measured by cephalic index (CI) and cranial vault asymmetry index (CVAI), and treating provider rating of success. Results Patients with Medicaid were more likely to complete treatment with residual flattening measured by CI and CVAI when compared to patients with private insurance (OR: 1.58, CI: 1.51–1.65, p < 0.001 and OR: 1.21, CI: 1.15–1.28, p < 0.001, respectively). Providers of patients with Medicaid were more likely to give a low rating of success following treatment (OR: 3.25, CI: 2.70–3.92, p < 0.001). Conclusions Our study investigating the impact of insurance status on helmet therapy across 21 states found that patients with Medicaid were more likely to experience residual flattening and have lower provider-rated outcomes compared to those with commercial insurance. Given significant caregiver burden posed by helmet therapy, which requires frequent visits and consistent helmet use, caregivers of patients with Medicaid may require greater support to reduce outcome disparities observed here.
Retrospective Analysis of a Modern Cohort of Dermatofibrosarcoma Protuberans From 2000 to 2018
Authors: Baig Imran T. , Lauck Kyle , Nguyen Quoc-Bao D. 
Published: January 2023

Background There is limited data on how demographics, tumor characteristics, and treatment methods affect overall survival in patients with dermatofibrosarcoma protuberans (DFSP). Objective To summarize characteristics of patients with DFSP, assess prognostic factors, and evaluate the impact of treatment modality on their overall survival. Methods We investigated DFSP using data for 4451 patients with histologically confirmed cases of DFSP diagnosed between 2000 and 2018 from the 18 US regional registries of the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Program. Results Older age ( P < .001) and large tumor size ( P = .006) were significantly associated with worse overall survival in controlled analysis. Older age ( P < .050), males ( P < .001), non-white race ( P < .001), and lower median household income ( P < .010) were more likely to present with larger tumor size. Different treatments were associated with patient characteristics. Older age ( P < .001), non-white race ( P < .032), larger tumor size ( P < .001), and head/neck location ( P < .001) were associated with patients receiving surgery and radiation instead of surgery only. Additionally, men ( P < .021), non-whites ( P < .001), lower median household income ( P < .001), and larger tumor size ( P = .003) were less likely to have Mohs micrographic surgery performed over excision. Conclusions Age at presentation and tumor size appeared to be notable prognostic factors. Although treatment modality did not significantly influence patient survival, certain patient characteristics are associated with different treatment modalities.
Effectiveness of carotid council in the treatment of carotid artery disease: Early-term outcomes of the multidisciplinary approach
Authors: Ozbek Ismail C , Durmaz Aysegul , Ozen Yucel , Demir Serkan , Celik Didem , Yalcinkaya Emre , Cunurlu Merve , Ugur Murat 
Published: January 2023

Objectives Carotid arterial stenosis could be treated by surgical or percutaneous stenting. In this study, we aimed to investigate the effectiveness of the carotid council on the outcomes of patients with carotid artery disease. Methods In this retrospective study, we analyzed the patients who had undergone carotid arterial revascularization from April 2014 to July 2022 in our hospital. All patients were evaluated in carotid council, which is constituted by neurologist, cardiologist and cardiovascular surgeon. Patient-specific treatment procedure was decided in the council. Demographics and early-term follow-up results of the patients were evaluated. Results Totally 95 procedures in 85 patients were analyzed during the study period. 27.4 % of the patients had significant contralateral carotid arterial stenosis. In 88 (92.6%) procedures, patients were treated by carotid endarterectomy, and 5 procedures were performed under regional anesthesia. Shunt usage was 6.0% during the surgery, and arteriotomy was repaired with primary sutures in 87.3%. Stent implantation was performed in 7 patients. There were 5 neurological adverse events after the carotid endarterectomy and 2 neurological events were after carotid arterial stenting. In each treatment group, one patient died after the procedure. In the follow-up period, restenosis was observed just in a patient who was treated with carotid endarterectomy and primary repair. Conclusion Although carotid artery disease could be treated in accordance with the guidelines, treatment procedures should be patient-specific. Carotid councils might be helpful in giving patient-specific decisions, thereby providing the patient-based treatment procedure and improving the outcomes of the patients with carotid artery disease.
Distribution of rare earth elements of Tunisian margin clays
Authors: Jamoussi Fakher , Lopez Galindo Alberto 
Published: January 2023

AbstractThe rare earth element (REE) content of the Tunisian Permian–Neogene shales have been studied to determine the origins of the clay minerals in these shales. The Permian–Neogene series overlies the Palaeozoic basement that has been studied via oil-drilling cores. This study of REEs was performed in various palaeogeographical domains of Tunisia, from the ‘Saharan Platform’ in the south to the ‘Nappes Zone’ in the north. In this work, those levels rich in illite (Palaeozoic, Triassic and Jurassic), smectite (Campanian–Maastrichtian) and palygorskite (continental Eocene) as well as some Miocene levels rich in halloysite are examined. The distribution of REEs in the Tunisian margin sediments is generally homogeneous, except for the Miocene levels containing halloysites. The normalization curves of REEs vs North American shale composite characterize the inherited clays regardless of the dominant minerals, except for a few cases of neoformation. The flat REE curves indicate a detrital origin of the studied clay levels.
Crystal chemistry of turkestanite, Dara-i-Pioz massif, Tajikistan
Authors: Kaneva Ekaterina , Radomskaya Tatiana , Belozerova Olga , Shendrik Roman 
Published: January 2023

AbstractThe results of combined single-crystal X-ray diffraction, electron probe microanalysis, Fourier microspectroscopy, and photoluminescence spectroscopy study of crystals of turkestanite from the Dara-i-Pioz deposit, Tien-Shan Mountains, Tajikistan are reported. It is a single-layer sheet silicate belonging to the ekanite group with a steacyite structural type. Averaged major-element analysis provided (wt.%): K2O 4.13(6), CaO 8.1(1), Na2O 2.3(1), ThO2 25.8(4), UO2 3.6(4) and SiO2 55.9(1). The averaged crystal-chemical formula for the studied turkestanite is (Th0.84U0.12)Σ0.96(Ca1.24Na0.65)Σ1.89(K0.75☐0.25)Σ1.00Si8O19.72(OH)0.28. Single-crystal structural refinement of turkestanite gave tetragonal, space group P4/mcc, a = 7.5708(3) Å, c = 14.7300(11) Å, V = 844.27(6) Å3 and Z = 2. Luminescence of the uranyl ion (UO2)2+ is observed in turkestanite. In the excitation spectrum, the bands corresponding to a charge transfer transition from the 2p states of the ligand to the 5f state of uranium were found.
HMGB1 mediates lipopolysaccharide-induced macrophage autophagy and pyroptosis
Authors: Shang Jiawei , Zhao Feng , Cao Yongmei , Ping Feng , Wang Wei , Li Yingchuan 
Published: January 2023

AbstractAutophagy and pyroptosis of macrophages play important protective or detrimental roles in sepsis. However, the underlying mechanisms remain unclear. High mobility group box protein 1 (HMGB1) is associated with both pyroptosis and autophagy. lipopolysaccharide (LPS) is an important pathogenic factor involved in sepsis. Lentivirus-mediated HMGB1 shRNA was used to inhibit the expression of HMGB1. Macrophages were treated with acetylation inhibitor (AA) to suppress the translocation of HMGB1 from the nucleus to the cytosol. Autophagy and pyroptosis-related protein expressions were detected by Western blot. The levels of caspase-1 activity were detected and the rate of pyroptotic cells was detected by flow cytometry. LPS induced autophagy and pyroptosis of macrophages at different stages, and HMGB1 downregulation decreased LPS-induced autophagy and pyroptosis. Treatment with acetylation inhibitor (anacardic acid) significantly suppressed LPS-induced autophagy, an effect that was not reversed by exogenous HMGB1, suggesting that cytoplasmic HMGB1 mediates LPS-induced autophagy of macrophages. Anacardic acid or an anti-HMGB1 antibody inhibited LPS-induced pyroptosis of macrophages. HMGB1 alone induced pyroptosis of macrophages and this effect was inhibited by anti-HMGB1 antibody, suggesting that extracellular HMGB1 induces macrophage pyroptosis and mediates LPS-induced pyroptosis. In summary, HMGB1 plays different roles in mediating LPS-induced autophagy and triggering pyroptosis according to subcellular localization.
The journey to a learning health system in primary care: a qualitative case study utilising an embedded research approach
Authors: Dammery Genevieve , Ellis Louise A. , Churruca Kate , Mahadeva Janani , Lopez Francisco , Carrigan Ann , Halim Nicole , Willcock Simon , Braithwaite Jeffrey 
Published: January 2023

AbstractBackgroundHealthcare systems may be resilient and adaptive, but they are not fit for purpose in their current state. Increasing threats to health system sustainability have underscored the need to move towards a learning health system in which research and data are used routinely in clinical practice to facilitate system improvement. This study aimed to establish which elements of the learning health system were being realised within a university-based general practice and determine acceptability from staff to embrace further the transition towards a learning health system.MethodsSemi-structured interviews were conducted with practice staff, including clinical and administrative staff, to determine the current state of the learning health system in the practice. An embedded researcher was placed within the general practice on a part-time basis to investigate the learning health system model. Interviews were transcribed and thematically analysed based on the National Academy of Medicine’s framework of learning health systems.ResultsIn total, 32 (91%) practice staff were interviewed, comprising general practitioners (n = 15), nurses (n = 3), administrative staff (n = 13), and a psychologist (n = 1). Participants indicated that the practice was operating with several characteristics of a learning health system (e.g., emphasising science and informatics; focusing on patient-clinician partnerships; applying incentives; supporting a continuous learning culture; and establishing structures and governance for learning). These measures were supported by the university-based setting, and resultant culture of learning. Nevertheless, there were areas of the practice where the learning health system could be strengthened, specifically relating to the use of patient data and informatics. Staff generally expressed willingness to engage with the process of strengthening the learning health system within their practice.ConclusionAlthough the idea of a learning health system has been gaining traction in recent years, there are comparatively few empirical studies presented in the literature. This research presents a case study of a general practice that is operating as a learning health system and highlights the utility of using the learning health system framework.
Risk thresholds for patients to switch between daily tablets and biweekly infusions in second-line treatment for advanced hepatocellular carcinoma: a patient preference study
Authors: Parikh Neehar D. , Girvan Allicia , Coulter Joshua , Gable Jonathon , Poon Jiat Ling , Kim Sangmi , Chatterjee Anindya , Boeri Marco 
Published: January 2023

Abstract
Background
Historically, high hepatocellular carcinoma (HCC)–related mortality has been, in part, due to lack of effective therapies; however, several systemic therapies have been recently approved for HCC treatment, including regorafenib and ramucirumab. These two treatments utilize different routes of administration (four daily tablets and biweekly intravenous infusions, respectively) and have different risks of adverse events (AEs). However, we lack data on patient preferences in balancing the route of administration and risk of AEs in patients with HCC. We aimed to determine patient preferences and trade-offs for second-line treatment in patients with HCC.

Methods
Patients with advanced or metastatic HCC were recruited through their physicians for this study. Patient preferences were assessed by using a modified threshold technique (TT) design in which respondents were asked two direct-elicitation questions before (assuming same safety and efficacy and only varying mode of administration) and after (incorporating the safety profiles of ramucirumab and regorafenib) the TT series on seven risks of clinically relevant AEs.

Results
In total, of the 157 patients recruited by their physicians, 150 were eligible and consented to participate. In the first elicitation question (assuming risk and efficacy were equivalent), 61.3% of patients preferred daily tablets. However, 76.7% of patients preferred the biweekly infusion when the safety profiles of the two available second-line therapies were included. The TT analysis confirmed that preferences for oral administration were not strong enough to balance out the risk of AEs that differentiate the two therapies.

Discussion
We found that when patients were asked to choose between a daily, oral medication and a biweekly IV medication for HCC, they were more likely to choose a daily, oral medication if efficacy and safety profiles were the same. However, when risks of AEs representing the safety profiles of two currently available second-line treatments were introduced in a second direct-elicitation question, respondents often selected an IV administration with a safety profile similar to ramucirumab, rather than oral tablets with a safety profile similar to regorafenib. Our findings indicate that the risk profile of a second-line treatment for HCC may be more important than the mode of administration to patients.
Identification of immune associated potential molecular targets in proliferative diabetic retinopathy
Authors: Gao Ying , Xue Min , Dai Bing , Tang Yun , Liu Jingyu , Zhao Changlin , Meng Hu , Yan Feng , Zhu Xiaomin , Lu Yan , Ge Yirui 
Published: January 2023

Abstract
Background
Diabetic retinopathy (DR) is one of the most common microvascular complications of diabetes and causes of blindness in developed countries. Our study was designed to identify immune-related genes involved in the progression of proliferative diabetic retinopathy (PDR).

Methods
The “GSE102485” dataset of neovascular membrane samples (NVMs) from type 1 and 2 diabetes mellitus patients was downloaded from the Gene Expression Omnibus database. Functional enrichment analyses, protein–protein interaction network (PPI) construction, and module analysis of immune pathways in NVMs and controls were conducted via Gene Set Enrichment Analysis and Metascape.

Results
The significantly upregulated hallmark gene sets in DR2 and DR1 groups were involved in five immune pathways. Only CCR4, CXCR6, C3AR1, LPAR1, C5AR1, and P2RY14 were not previously reported in the context of PDR molecular pathophysiology. Except for P2RY14, all of the above were upregulated in retinal samples from experimental diabetes mouse models and human retina microvascular endothelial cells (HRMECs) treated with high glucose (HG) by quantitative Real Time Polymerase Chain Reaction (qRT-PCR).

Conclusion
The genes identified herein provide insight into immune-related differential gene expression during DR progression.
Sharing real-world data for public benefit: a qualitative exploration of stakeholder views and perceptions
Authors: Baxter Susan , Franklin Matthew , Haywood Annette , Stone Tony , Jones Monica , Mason Suzanne , Sterniczuk Kamil 
Published: January 2023

Abstract
Background
There has been an increasing interest in the use of “real-world” data to inform care decision making that could lead to public health benefit. Routinely collected service and activity data associated with the administration of care services and service-users (such as electronic health records or electronic social care records), hold potential to better inform effective and responsive decision-making about health and care services provided to national and local populations. This study sought to gain an in-depth understanding regarding the potential to unlock real world data that was held in individual organisations, to better inform public health decision-making. This included sharing data between and within health service providers and local governing authorities, but also with university researchers to inform the evidence base.

Methods
We used qualitative methods and carried out a series of online workshops and interviews with stakeholders (senior-level decision-makers and service leads, researchers, data analysts, those with a legal and governance role, and members of the public). We identified recurring themes in initial workshops, and explored these with participants in subsequent workshops. By this iterative process we further refined the themes identified, compared views and perceptions amongst different stakeholder groups, and developed recommendations for action.

Results
Our study identified key elements of context and timing, the need for a different approach, and obstacles including governmental and legal, organisational features, and process factors which adversely affect the sharing of real world data. The findings also highlighted a need for improved communication about data for secondary uses to members of the public.

Conclusion
The Covid-19 pandemic context and changes to organisational structures in the health service in England have provided opportunities to address data sharing challenges. Change at national and local level is required, within current job roles and generating new jobs roles focused on the use and sharing of real-world data. The study suggests that actions can be taken to unlock the potential of real-world data for public health benefit, and provides a series of recommendations at a national level, for organisational leaders, those in data roles and those in public engagement roles.
In vitro and in vivo anthelmintic and chemical studies of Cyperus rotundus L. extracts
Authors: El-Wakil Eman S. , Shaker Shimaa , Aboushousha Tarek , Abdel-Hameed El-Sayed S. , Osman Ezzat E. A. 
Published: January 2023

Abstract
Background
Trichinellosis, a zoonosis caused by the genus Trichinella, is a widespread foodborne disease. Albendazole, one of the benzimidazole derivatives, is used for treating human trichinellosis, but with limited efficacy in killing the encysted larvae and numerous adverse effects. Cyperus rotundus L. is a herbal plant with a wide range of medicinal uses, including antiparasitic, and is frequently used in traditional medicine to treat various illnesses.

Methods
LC-ESI-MS was used to identify the active phytoconstituents in the methanol extract (MeOH ext.) of the aerial parts of C. rotundus and its derivate fractions ethyl acetate (EtOAc fr.), petroleum ether (pet-ether fr.), and normal butanol (n-BuOH fr.). The in vivo therapeutic effects of C. rotundus fractions of the extracts were evaluated using the fraction that showed the most promising effect after detecting their in vitro anti-Trichinella spiralis potential.

Results
C. rotundus extracts are rich in different phytochemicals, and the LC-ESI-MS of the 90% methanol extract identified 26 phenolic compounds classified as phenolic acids, flavonoids, and organic acids. The in vitro studies showed that C. rotundus extracts had a lethal effect on T. spiralis adults, and the LC50 were 156.12 µg/ml, 294.67 µg/ml, 82.09 µg/ml, and 73.16 µg/ml in 90% MeOH ext., EtOAc fr., pet-ether fr. and n-BuOH fr., respectively. The n-BuOH fr. was shown to have the most promising effects in the in vitro studies, which was confirmed by scanning electron microscopy. The in vivo effects of n-BuOH fr. alone and in combination with albendazole using a mouse model were evaluated by counting adults in the small intestine and larvae in the muscles, in addition to the histopathological changes in the small intestine and the muscles. In the treated groups, there was a significant decrease in the number of adults and larvae compared to the control group. Histopathologically, treated groups showed a remarkable improvement in the small intestine and muscle changes. Remarkably, maximal therapeutic effects were detected in the combination therapy compared to each monotherapy.

Conclusion
Accordingly, C. rotundus extracts may have anti-T. spiralis potential, particularly when combined with albendazole, and they may be used as synergistic to anti-T. spiralis medication therapy.
Pandemic preparedness and management in European out-of-hours primary care services – a descriptive study
Authors: Rebnord Ingrid Keilegavlen , Rortveit Guri , Huibers Linda , Dale Jonas Nordvik , Smits Marleen , Morken Tone 
Published: January 2023

Abstract
Background
Primary care is the first point of contact for all acute health problems. As such, primary care was at the frontline in the COVID-19 pandemic, playing a significant role in clinical responses and information to the public. This study aimed to describe the variations in patient management strategies used in the out-of-hours services in different European countries during the first phase of the pandemic.

Method
We conducted a cross-sectional web-based survey in August 2020, selecting key informants from European countries using European networks. The questionnaire was developed in collaboration with researchers in the field of out-of-hours primary care. We performed descriptive analyses per region, structuring results into themes.

Results
Key informants from 38 regions in 20 European countries responded. Seven regions reported that their out-of-hours services had a pandemic preparedness plan, three had trained on the plan, and two had stockpiles of personal protection equipment before the outbreak. Extension of telephone triage lines and establishment of local infection-control teams and clinics were the main patient management strategies. Other strategies for patient contacts were also used in the regions, such as video-consultations (13 regions), electronic consultations (21 regions), patient’s car as alternative waiting room (19 regions), outside tents for testing (24 regions), “drive-through” testing (26 regions), and separate departments for infected patients (14 regions).

Conclusion
Few out-of-hours services were well prepared for a pandemic, but all expanded and reorganized rapidly, adopting new strategies for patient management and treatment. The results could be useful for planning of organization preparedness of out-of-hours primary care service for future pandemics.